🔗 Share this article

This year's prestigious award in Physiology or Medicine has been awarded for transformative discoveries that clarify how the immune system targets harmful infections while sparing the body's own cells.

A trio of esteemed scientists—from Japan Prof. Sakaguchi and American experts Dr. Brunkow and Dr. Ramsdell—share this accolade.

Their research uncovered specialized "security guards" within the immune system that remove malfunctioning immune cells capable of attacking the body.

The discoveries are now paving the way for innovative therapies for immune disorders and cancer.

These winners will divide a monetary award worth 11 million Swedish kronor.

Decisive Findings

"The research has been essential for comprehending how the body's defenses operates and the reason we don't all suffer from severe self-attack conditions," stated the head of the award panel.

This team's studies address a core mystery: How does the defense system protect us from numerous infections while keeping our healthy cells unharmed?

The immune system employs white blood cells that search for signs of infection, including pathogens and bacteria it has never encountered.

These defenders utilize detectors—known as recognition units—that are produced by chance in countless variations.

That gives the defense network the capacity to fight a broad range of threats, but the unpredictability of the process unavoidably creates white blood cells that may attack the body.

Security Guards of the Immune System

Researchers previously understood that some of these problematic white blood cells were eliminated in the immune organ—the site where immune cells develop.

The latest award recognizes the discovery of regulatory T-cells—described as the immune system's "peacekeepers"—which patrol the body to neutralize any defenders that attack the body's own tissues.

It is known that this mechanism malfunctions in autoimmune diseases such as type-1 diabetes, multiple sclerosis, and RA.

A Nobel panel added, "The findings have established a novel area of investigation and spurred the development of new therapies, for instance for cancer and autoimmune diseases."

Regarding malignancies, T-regs prevent the body from fighting the growth, so studies are aimed at reducing their numbers.

For self-attack disorders, experiments are testing boosting regulatory T-cells so the body is not under attack. A comparable method could also be effective in minimizing the chances of organ transplant rejection.

Innovative Studies

Prof Shimon Sakaguchi, of Osaka University, conducted tests on mice that had their immune gland removed, leading to autoimmune disease.

The researcher showed that injecting defense cells from other mice could stop the disease—implying there was a mechanism for preventing defenders from attacking the host.

Dr. Brunkow, affiliated with the Institute for Systems Biology in Seattle, and Fred Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were investigating an inherited immune disorder in rodents and people that resulted in the identification of a gene critical for the way regulatory T-cells function.

"The pioneering research has uncovered how the immune system is kept in check by T-reg cells, preventing it from mistakenly attacking the healthy cells," commented a prominent biological science specialist.

"This work is a remarkable example of how basic physiological research can have broad implications for public health."